SlideShare a Scribd company logo
1 of 86
Download to read offline
1
COLLEGE OF MEDICINE AND HEALTH
SCIENCE
DEPARTMENT OF PUBLIC HEALTH (C1)
SEMINAR TITLE:- SYNDROMIC APPROACHS TO STIs /STDs
By: NUREDIN AMAN
Moderator Dr. MAHDER K.
2
OUTLINE
 OVERVIEW OF MALE AND FEMALE GENITAL ANATOMY
 DEFINE OF STDs
 DEFINE EPIDEMOLOGY OF STDs
 EXPLAIN SYNDROMIC APPROACH
 ADVANTAGE AND DISADVANTAGE SYNDROMIC APPROACH
 EXPLAIN MOST COMMON STI SYNDROME
 REVIEW OF FLOW CHART
 ETIOLOGY OF EACH SYNDROME
 CLINICAL MANIFESTATION OF EACH SYNDROME
 COMPLICATION OF ETIOLOGY
 TREATMENT OF EACH SYNDROME
3
Female reproductive
 Vulva or Pudendum (external genitalia)
 Labia majora
 Labia minora
 Vestibule of the vagina ( urogenital sinus)
4
Conti……
 Clitoris
 Bulbs of the vestibule
 Vagina
 Uterus
 Uterine tube /fallopian / oviducts
 Ovaries (oocyte and hormones)
5
Upper genitalia 6
External genitalia
7
8
Male reproductive organ
 INCLUDE :
 Supporting structures
 Scrotum
 Penis
 Testes (gonads)
 A system of ducts
 Epididymis
 Ductus (vas) deferens ( part of spermatic cord)
 Ejaculatory ducts
9
Conti…
 Urethra ( part of excretory)
 Accessory sex glands
Seminal vesicles
Prostate
Bulbourethral glands (Cowper’s gland)_
10
Internal genitalia
11
External genitalia
12
Sexually transmitted disease
 The term sexually transmitted diseases (STDs) is used to
describe disorders spread by intimate contact.
 Although this usually means sexual intercourse, it also
includes close body contact, kissing, cunnilingus,
anilingus, fellatio, mouth–breast contact, and anal
intercourse.
 Many STDs can also be transmitted to the fetus in utero
by transplacental spread or passage through the birth
canal and via lactation during the neonatal period.
13
Sexually transmitted disease
 A group of over 50 infectious diseases are included
under STIs.
 Although their etiologies involve a number of
organisms, the infections present themselves
commonly in the following syndromes (genital ulcer,
urethral discharge, vaginal discharge, lower
abdominal pain, scrotal swelling, inguinal bubo and
neonatal conjunctivitis)
14
Epidemiology of STIs
 Even though there is little information on the incidence and
prevalence of STIs in Ethiopia, the problem of STIs is generally
believed to be similar to that of other developing countries.
 According to 2011EDHS, 1%, of each Ethiopian women and men
reported having had an STI in the past 12 months before the
survey. Three percent of women and 2% of men reported having
had an abnormal genital discharge.
 Also 1% of each women and men reported having had a
genital sore or ulcer in the 12 months preceding the survey.
These numbers may be underestimated because
respondents could be embarrassed or ashamed to admit
having STIs. 15
15
Conti..
 The single point adult HIV prevalence estimate for the year 2014 is
1.14%. Taking syphilis and HIV as proxy indicators, the STI
prevalence is in a declining trend.
 In the STI surveillance study which was conducted from
January - June 2013 in 8 health facilities located in Amhara,
Oromia and Addis Ababa by EHNRI in collaboration with
CDC-E, a total of 636 STI cases were reported from eight
sentinel surveillance sites and the commonest syndrome was
vaginal discharge (50%), followed by urethral discharge
(31%), genital ulcerative disease (9%), lower abdominal pain
(7.3%) and two syndrome were present in few patients (3%).
16
Conti..
 About 16% of the STI patients were co-infected with HIV
(8.1% male and 21%female) and HIV prevalence is higher on
STI patients with lower abdominal pain (41%) and genital
ulcer (24.5%). Young people, in the age group 20-34 yrs, were
the highly affected ones (68.2%), with a larger proportion
being females (61%)
17
Conti…
 Sexually transmitted infections remain a public health
problem of major importance in both developed and
developing countries, but are specially so in developing
countries where access to diagnostic and treatment facilities
is inadequate, very limited or non existent at all. In many
developing countries throughout the world STIs rank among
the top ten conditions for which adults seek health care.
These diseases are important for three reasons, because of
their magnitude, their potential for causing serious
complications and their linkage with HIV/AIDS.
18
Conti..
 According to a WHO report, in 1995 an estimated 340
million new cases of the five most common curable STIs
occurred
 globally in both men and women of 15 - 49 age range. On
average an estimated 930,000 people are infected every day
with curable STI globally.
19
20
21
Syndromic approach
 Syndromic approach is called “Comprehensive approach” because in
addition to the provision of treatment it includes: education of the
patient, condom supply, counseling, partner notification and
management and HIV testing and counseling
 Treatment for each syndrome is directed against the main organisms within
that geographical setting responsible for the syndrome.
 The syndromic approach has been shown to be highly effective for the
management of majority of the STI. Prompt and efficient case detection and
treatment, results in immediate health benefits for individual patients.
22
23
The commonly encountered STI syndromes are:
 Urethral discharge in men
 Genital ulcer
 Vaginal discharge
 Lower abdominal pain in women
 Inguinal bubo
 Scrotal swelling
 Neonatal conjunctivitis.
24
25
 Introduction to Flow Charts
 For each syndrome a clinical algorithm is developed to be followed
in managing STI patients.
 A flow chart (also known as an algorithm) is a decision and action
tree. It is like a map that guides the health worker to go through a
series of decisions and actions. Each decision or action is enclosed in
a box, with one or two routes leading out to another box, containing
another decision or action.
26
Conti..
 Benefits of using flow-charts
 They can be used at any time in all types of health facilities.
 They suggest clear decisions
 Each flow-chart is made up of a series of three steps.
 These are:
 The clinical problem: is what the patient complains of, i.e. the patient’s presenting symptoms
 The decision that needs to be taken: this is the box, which requires further information, which the
health care provider finds out by taking a history or examining the patient.
 The action that needs to be carried out: Each of the exit paths leads to an action or do box. This is
the box that instructs the service provider on what action to take.
27
28
URETHRAL DISCHARGE SYNDROME
 Urethral discharge is the presence of abnormal secretions from the
distal part of the urethra and it is the characteristic manifestation of
urethritis.
 Urethritis is usually due to sexually transmitted infections although
urinary tract infections may produce similar symptoms.
 Urethral discharge is one of the commonest sexually transmitted
infections among men in our country. Usually urethral discharge is
accompanied by burning sensations (dysuria) during micturition.
29
CONTI…
 Person with urethral discharge can also have
 increased frequency
 urgency of urination
 itching sensation of urethra
 The amount and nature of the discharge vary according to the
causative agents and other factors like prior treatments with
antibiotics.
30
Conti…
 The appearance of the discharge can be
 purulent or mucoid
 clear, white, or yellowish-green
 Sometimes it can be associated with scrotal swelling
and pain which tends to be unilateral.
31
 The causative agents of urethral discharge syndrome are many; but the
two most common causative agents of the syndrome are
 Neisseria gonorrhea
 Chlamydia trachomatis ( 81% and 36.8% respectively according the
2014 EPHI gonococcal antimicrobial sensitivity validation study ) .
 Some of the other causative micro-organisms are mycoplasma
genitalium,Trichomonas vaginalis, and Ureaplasma urealyticum.
 Most of the time urethral discharge is due to mixed infection of
Neisseria gonorrhea and Chlamydia trachomatis
ETIOLOGY OF URETHRAL DISCHARGE SYNDROME 32
 The urethritis caused by N. gonorrhea has usually an acute onset with
profuse and purulent discharge and
 The one caused by C. trachomatis has sub-acute onset with scant
mucopurulent discharge.
 The other common signs and symptoms are burning sensation during
micturition, urgency and frequency of urination with itching sensation
of the urethra.
 The signs and symptoms of complications of the syndrome are
testicular pain and swelling, polyarthralgia, tenosynovitis, arthritis, skin
lesions and constitutional symptoms
CLINICAL MANIFESTATIONS OF URETHRAL
DISCHARGE SYNDROME
33
34
COMPLICATIONS OF URETHRAL DISCHARGE
SYNDROME
 :

 Acute complications
• Disseminated gonococci syndrome
• Perihepatitis
• Acute epididymo-orchitis
 Chronic complications
 • Urethral stricture
 • Infertility
 • Reiter’s syndrome(urethritis , conjunctivitis $ cervicitis)
35
36
TREATMENT
 Ceftriaxone 250mg IM stat/Spectinomycin 2 gm IM stat Plus
 Azithromycin 1gm po stat/Doxycycline 100 mg po bid for 7
days/Tetracycline 500 mg po qid for 7 days/Erythromycin 500 mg po qid
for 7 days in cases of contraindications for Tetracycline (children and
pregnancy)
 Note: The preferred regimen is Ceftriaxone 250mg IM stat plus
Azithromycin 1gm po stat
37
 Metronidazole 2 gm po. stat/Tinidazole 1gm po once for 3
days (Avoid Alcohol!)
 • Azithromycin 1 g orally in a single dose (only if not used
during the initial episode to address doxycycline resistant
M.genitalium)
TREATMENT OF PERSISTENT/RECURRENT URETHRITIS
SYNDROME
38
GENITAL ULCER SYNDROME
 Genital ulcer is an open sore or a break in the continuity of the
skin or mucous membrane of the genitalia as a result of sexually
acquired infections.
 Commonly genital ulcer is caused by bacteria and viruses.
 Genital ulcer facilitates transmission of HIV more than other
sexually transmitted infections because it disrupts continuity of
skins and mucous membranes significantly
39
40
ETIOLOGY OF GENITAL ULCER SYNDROME
 There are different kinds of bacteria and viruses which
cause genital ulcer.
 Some of the common etiologies of genital ulcer
syndrome are:
 Herpes simplex virus (HSV-1 and HSV-2)
 Treponema pallidum
 Haemophilius ducreyia
 Chlamydia trachomatis
41
CLINICAL MANIFESTATION
Genital ulcer is caused by different causative agents and due to
this fact genital ulcer has different kinds of clinical manifestations.
Common clinical manifestations of genital ulcer are:
• Constitutional symptoms such as fever, headache, malaise
and muscular pain
• Recurrent painful vesicles and irritations
• Shallow and non-indurated tender ulcers
42
Conti...
• Common sites in male are
 glance penis , prepuce and penile shaft
• Common sites in women are
 vulva $ perineum,
 vagina and cervix and can cause occasionally severe vulvo- vaginitis and
necrotizing cervicitis
• Painless indurated ulcer(Chancre)
• Regional lymph adenopathy
43
COMPLICATIONS OF GENITAL ULCER
SYNDROME
• Locally destructive granulomatous lesions occur
(Gummas) on the skin, liver, bones, or other organs
• Tabes dorsalis and dementia, often with paranoid features
• Latent meningovascular parenchymatous
• Optic atrophy
• General paresis
• Aortic aneurysm and aortic valve insufficiency
44
45
TREATMENT OF GENITAL ULCER SYNDROME
 1. Treatment for Non- Vesicular Genital Ulcer: Benzathine penicillin 2.4
million units IM stat /Doxycycline(in penicillin allergy) 100mg bid for 14
days plus
 Ciprofloxacin 500mg bid orally for 3 days /Erythromycin 500mg tab
qid for 7 days plus Acyclovir 400mg tid orally for 10 days (or 200mg
five times per day of 10 day)
 2. Treatment for Vesicular, multiple or recurrent genital ulcer Acyclovir
200 mg five times per day for 10 days Or Acyclovir 400 mg tid for 7
day
 3. Treatment for recurrent infection: Acyclovir 400 mg tid for 7days
46
VAGINAL DISCHARGE SYNDROME
 Physiologically women have vaginal discharge which is white mucoid,
odor less and nonirritant, thin or thick based on menstrual cycle. There
is individual variation in the amount of normal vaginal discharges.
 Abnormal vaginal discharge which is STI related is abnormal in color,
odor and amount.
 In another word abnormal vaginal discharge is there when a women
notices a change in color, odor and amount accompanied by pruritus.
47
48
ETIOLOGY OF VAGINAL DISCHARGE
SYNDROME
 The most common causes of vaginal discharge syndrome are
 Bacterial vaginosis (Gardnerella vaginalis) is the leading cause of
vaginal discharge in Ethiopia followed by
 candidiasis,
 trichomoniasis,
 gonococcal and
 chlamydia cervicitis in that order.
49
CLINICAL MANIFESTATIONS
The classical manifestation of vaginal discharge is
discharge from the vagina. The discharge can be
• Thin, homogenous whitish discharge with fishy odor
• Thick, profuse, malodorous, yellow-green, frothy itchy
• Purulent exudate from the cervical Os
• White , thick and curd like discharge coating the walls of
the vagina
50
Conti…
 The other manifestations are:
 vulvo-vaginal pruritus
 , irritation of vulva,
 dyspareunia, dysuria, and frequency of urination.
Physical examination may reveal dry congestion of the vulva with
discharge. There can be signs of cervicitis during speculum
examination which are redness and contact bleeding from the
cervix, spotting and endo cervical discharge.
51
Conti...
 The following are the common risk factors for development of
vaginal discharge syndrome secondary to cervicitis:
 Multiple sexual partners in the last 3 month
 New sexual partner in the last 3 month
 Ever traded sex
 Age below 25 years
 The presences of one or more risk factor suggest cervicitis.
52
COMPLICATIONS
 Untreated vaginal discharge can cause reproductive, sexual and other health
complications. Some of the complications are:
• Pelvic Inflammatory Disease (PID)
• Adhesions and intestinal obstruction
• Ectopic pregnancy
• Premature Rupture of Membrane (PROM) in case of pregnant wom
• Pre-term labor in case of pregnant women
• Low birth weight
• Infertility
53
54
TREATMENT OF VAGINAL DISCHARGE
SYNDROME
 Risk Assessment Positive
 Ceftriaxone 250mg IM stat/Spectinomycin 2 gm IM stat Plus
Azithromycin 1gm po stat/Doxycycline 100 mg po bid Plus
Metronidazole 500 mg bid for 7 days
If discharge is white or curd-like add Clotrimazole
vaginal pessary 200 mg at bed time for 3 days or 7 days
55
Conti…
 Risk Assessment Negative
 Metronidazole 500 mg bid for 7 days If discharge is white
or curd-like add
 Clotrimazole vaginal pessary 200 mg at bed time for 3
days
56
5. LOWER ABDOMINAL PAIN/PELVIC
INFLAMMATORY DISEASE (PID)
 Pelvic inflammatory disease (PID) refers to a clinical
syndrome resulting from ascending infection from the cervix and/or
vagina.
 PID comprises a spectrum of inflammatory disorders of the upper female genital
tract, including any combination of endometritis, salpingitis, tubo-ovarian abscess
and pelvic peritonitis.
 The inflammation may also spread to the liver, spleen or appendix.
 The vast majority of PID with or without pelvic abscess improves with antibiotics
alone and the fever usually subsides in less than 72 hours. However, failure to
improve within 72 hours after antibiotic treatment indicates failure of medical
treatment and the patient should be referred for surgical evaluation and
treatment.
57
ETIOLOGY
PID is frequently poly-microbial. The commonest pathogens associated with PID,
which are transmitted sexually, are C. trachomatis and N. gonorrhoea. Other
causes which may or may not be transmitted sexually include:
• Mycoplasma genitalium
• Bacteroides species
• E. coli
• H. influenza
• Streptococcus
58
Clinical manifestation
 The commonest manifestations of pelvic inflammatory diseases
include
• Lower abdominal pain
• Abnormal vaginal discharge
• Inter-menstrual or post coital bleeding
• Dysuria
• Backache
• Fever, nausea and vomiti
59
COMPLICATIONS OF LOWER ABDOMINAL PAIN
SYNDROME
If patients with LAP syndrome are not treated appropriately and adequately the
following life threatening complications may occur.
• Peritonitis and intra-abdominal abscess
• Adhesions and intestinal obstruction
• Ectopic pregnancy
• Infertility
• Chronic pelvic pain
• Recurrent PID
60
61
TREATMENT OF LOWER ABDOMINAL PAIN
SYNDROME
The treatment regimen should cover all possible
causative agents. The recommended treatment
regimen for lower abdominal pain syndrome is:
For outpatient
 Ceftriaxone 250 mg IM stat /Spectinomycin 2gm
i.m stat Plus Azithromycin 1gm po stat/Doxycycline
100 mg po b.i.d for 14 days Plus Metronidazole 500
mg po b.i.d for 14 day
62
Conti….
 INDICATION FOR INPATIENT TREATMENT
 Hospitalization of patients with acute PID should be seriously considered
when:
 The diagnosis is uncertain
 • Surgical emergencies such as appendicitis and ectopic pregnancy cannot
be exclude
 • Pelvic abscess is suspected
 • Severe illness precludes management on an outpatient basis
 • The patient is pregnant
 • Patient has failed to respond to outpatient therapy.
 • PID in HIV patients
63
SCROTAL SWELLING SYNDROME
 Scrotal swelling can be caused by trauma, tumor, and torsion of
the testis or inflammation of the epididymis.
Mostly the inflammation of the epididymis is caused by sexually
transmitted diseases. The cause of scrotal swelling can vary
depending on the age of the patient.
Among patients who are younger than 35 years, the swelling is likely
to be caused by sexually transmitted infections.
64
65
ETIOLOGY SCROTAL SWELLING SYNDROME
The cause of scrotal swelling syndrome can be infectious or non-
infectious. Infectious scrotal swelling caused by:
• N. gonorrhea
• C. trachomatis
• T. pallidum
• M. tuberculosis
• Mumps virus
66
CLINICAL MANIFESTATIONS OF SCROTAL
SWELLING
Scrotal swelling can manifest itself with different signs and
symptoms. Some of the signs and symptoms of
scrotal swelling are:
• Pain and swelling of the scrotum
• Tender and hot scrotum on palpation
• Edema and erythema of the scrotum
• Dysuria
• Sometimes frequency and urethral discharge can be thereIt is
important to exclude other causes of scrotal swelling like testicular
torsion, trauma, and incarcerated inguinal hernia as they may require
urgent referral for proper surgical evaluation and management
67
COMPLICATIONS OF SCROTAL SWELLING
SYNDROME
The common complications of scrotal swelling syndrome are:
• Destruction and scarring of testicular tissues
• Infertility
• Impotence
• Prostatitis
68
69
TREATMENT OF SCROTAL SWELLING
SYNDROME
Ceftriaxone 250mg i.m stat/ Spectinomycin 2gms i.m stat.
Plus
Azithromycin 1gm po stat/ Doxycycline 100mg po bid for 7
days/ Tetracycline 500mg qid for 7 days
70
INGUINAL BUBO SYNDROME (SWOLLEN
GLANDS
 INGUINAL BUBO SYNDROME (SWOLLEN GLANDS)
Inguinal bubo is defined as swelling of inguinal lymph nodes as a result of
STIs. It should be remembered that infections on the lower extremities or in
the perineum could produce swelling of the inguinal lymph nodes but
strictly speaking this regional enlargement of lymph nodes should not be
regarded as inguinal bubo.
71
72
ETIOLOGY
The common causes of inguinal and femoral bubo are:
• Chlamydia trachomatis (L1, L2 and L3)
• Klebsiella granulomatis (donovanosis)
• Treponema pallidum
• Haemophilius ducreyia
CLINICAL MANIFESTATIONS
• Constitutional symptoms of fever, headache and pain
• Tender unilateral or bilateral lymphadenopathy forms a classical
“groove sign” in the inguinal area
• Fluctuant abscess formation which forma coalesce mass (bubo)
• Some time concomitantly occur with genital ulcer
73
COMPLICATIONS
 Fistula or sinus formation
 Multiple draining sinus
 Extensive ulceration of genitalia
 Extensive scarring
 Proctocolitis with tenesmus and bloody purulent discharge.
 Retroperitoneal lymphadenopathy
 Chronic untreated LGV may result in lymphatic obstruction, elephantiasis
of the genitalia
 Rarely hematogenous dissemination to lung, liver, spleen and bone
74
75
 TREATMENT OF INGUINAL BUBO
 The treatment regimen for inguinal bubo syndrome in Ethiopia is:
 Ciprofloxacin 500mg bid orally for 3 days
 Plus
 Doxycycline 100 mg bid orally for 14 days /Erythromycin 500mg po qid
for 14 days.
 If patient have genital ulcer , add Acyclovir 400mg tid orally for 10 days(
or 200mg five times per day for 10 days)
 Note: surgical incisions are contraindicated; aspirate pus with
hypodermic needle through the health skin
76
NEONATAL CONJUNCTIVITIS
 Neonatal conjunctivitis (ophthalmia neonatorum) is an ocular redness,
swelling and drainage which can be sometimes purulent due to pathogenic
agents or irritant chemicals occurring in infants less than 4 weeks of age.
 In cases of neonatal conjunctivitis due to pathogenic agents, the neonates
get the infections from their
 infected mothers. Neonatal conjunctivitis can cause loss of sight if it is not
managed properly and promptly.
 Neonatal conjunctivitis due to sterile chemical irritants can be resolved by
itself within 48 hours without any intervention.
77
78
ETIOLOGY OF NEONATALCONJUNCTIVITIS
can be disease causing micro-organisms or sterile chemicals which are irritant
and applied for preventive purposes.
Some of the common etiologic causes of neonatal conjunctivitis are:
 N. gonorrhea
 S. pneumoniae
 H. influenzae
 S. aureus
 The commonest irritant chemical that causes neonatal conjunctivitis is silver
nitrate solution, which is applied to the eye of the neonate for prophylactic
purposes
79
Conti…
COMMON RISK FACTORS OF NEONATAL
CONJUNCTIVITIS
• Maternal infection with STI
• Exposure of the infant to infectious organisms
• Inadequacy of ocular prophylaxis immediately after birth
• Premature rupture of membrane
• Ocular trauma during delivery
80
CLINICAL MANIFESTATIONS OF NEONATAL CONJUNCTIVITIS
The common clinical presentations of neonatal conjunctivitis
(ophthalmia neonatorum) are:
• Red and edematous conjunctiva
• Edematous eye lead
• Discharge which may be purulent
• Orbital cellulitis in more serious cases
81
COMPLICATIONS OF NEONATAL CONJUNCTIVITIS
Neonatal conjunctivitis can lead to some serious ophthalmic complications
if it is not managed promptly. Some of the complications of neonatal
conjunctivitis (ophthalmia neonatorum) are:
• Pseudo membrane formation
• Corneal edema
• Thickened palpebral conjunctiva
• Corneal opacification
• Corneal perforation
• Endophthalmitis
• Blindness
82
83
TREATMENT OF NEONATAL CONJUNCTIVITIS
(OPHTHALMIA NEONATORUM
 Ceftriaxone 50mg/kg IM stat maximum dose 125/
Spectinomycin 25 mg/kg IM stat maximum dose 75mg plus
 Erythromycin 50mg/kg orally in four divided doses for 14
days
Note: TTC is used as prophylaxis for neonatal conjunctivitis but
note for treatment
84
 REFERENCE
 NATIONAL GUIDELINES FOR THE MANAGEMENT OF STDs/STIs USING SYNDROMIC
APPROACH ( FMOH) JULY 2015
 EPHTI
 WHO GUIDELINES FOR THE MANAGEMENT OF STDs/STIs USING SYNDROMIC
APPROACH JULY 2021
85
THANK YOU
86

More Related Content

Similar to Syndromic approaches of sexually transmitted diseases

sexually transmitted disease
sexually transmitted diseasesexually transmitted disease
sexually transmitted diseaseMuni Venkatesh
 
Chapter27.pptx
Chapter27.pptxChapter27.pptx
Chapter27.pptxShinee13
 
Geriatric health communicable diseases and Egypt
Geriatric health communicable diseases and EgyptGeriatric health communicable diseases and Egypt
Geriatric health communicable diseases and EgyptHatem Refaat El-Sheemy
 
UTI-in-pregnancy in i pointofmidwifery.pdf
UTI-in-pregnancy in i pointofmidwifery.pdfUTI-in-pregnancy in i pointofmidwifery.pdf
UTI-in-pregnancy in i pointofmidwifery.pdfJuma675663
 
Recent Advances in Endometriosis
Recent Advances in EndometriosisRecent Advances in Endometriosis
Recent Advances in EndometriosisShivani Sachdev
 
Sexually transmitted diaseases
Sexually transmitted diaseasesSexually transmitted diaseases
Sexually transmitted diaseasesdraditi7in7
 
Infections of the urinary tract
Infections of the urinary tract Infections of the urinary tract
Infections of the urinary tract Bimel Kottarathil
 
1-macedaWhat other assessment data would be helpful for the nu.docx
1-macedaWhat other assessment data would be helpful for the nu.docx1-macedaWhat other assessment data would be helpful for the nu.docx
1-macedaWhat other assessment data would be helpful for the nu.docxteresehearn
 
Assess the Prevalence of Self Reported Vaginal Discharge, Perceived Causes an...
Assess the Prevalence of Self Reported Vaginal Discharge, Perceived Causes an...Assess the Prevalence of Self Reported Vaginal Discharge, Perceived Causes an...
Assess the Prevalence of Self Reported Vaginal Discharge, Perceived Causes an...ijtsrd
 
Guideline itu en transplantado organo solido
Guideline itu en transplantado organo solidoGuideline itu en transplantado organo solido
Guideline itu en transplantado organo solidoAlex Castañeda-Sabogal
 
Medicine (non resp) treatment guidelines Govt of India
Medicine (non resp) treatment guidelines Govt of India Medicine (non resp) treatment guidelines Govt of India
Medicine (non resp) treatment guidelines Govt of India Dr Jitu Lal Meena
 
Gonorrhoea & Syphilis
Gonorrhoea & Syphilis Gonorrhoea & Syphilis
Gonorrhoea & Syphilis Anoop Uniyal
 
Causes and Consequences of Back Pain
Causes and Consequences of Back PainCauses and Consequences of Back Pain
Causes and Consequences of Back Painkomalicarol
 
Acute pelvic inflammatory disease
Acute pelvic inflammatory diseaseAcute pelvic inflammatory disease
Acute pelvic inflammatory diseaseprithvi2911
 
Infections of the urinary tract final
Infections of the urinary tract finalInfections of the urinary tract final
Infections of the urinary tract finalBimel Kottarathil
 
Respond  on two different days who selected at least one different  .docx
Respond  on two different days who selected at least one different  .docxRespond  on two different days who selected at least one different  .docx
Respond  on two different days who selected at least one different  .docxwilfredoa1
 
Comparative Study of Visual, Clinical and Microbiological Diagnosis of White ...
Comparative Study of Visual, Clinical and Microbiological Diagnosis of White ...Comparative Study of Visual, Clinical and Microbiological Diagnosis of White ...
Comparative Study of Visual, Clinical and Microbiological Diagnosis of White ...iosrjce
 
FOURNIER’S GANGRENE: REVIEW OF 57 CASES IN TERTIARY INSTITUTION
FOURNIER’S GANGRENE: REVIEW OF 57 CASES IN TERTIARY INSTITUTIONFOURNIER’S GANGRENE: REVIEW OF 57 CASES IN TERTIARY INSTITUTION
FOURNIER’S GANGRENE: REVIEW OF 57 CASES IN TERTIARY INSTITUTIONAnil Haripriya
 

Similar to Syndromic approaches of sexually transmitted diseases (20)

sexually transmitted disease
sexually transmitted diseasesexually transmitted disease
sexually transmitted disease
 
Chapter27.pptx
Chapter27.pptxChapter27.pptx
Chapter27.pptx
 
Geriatric health communicable diseases and Egypt
Geriatric health communicable diseases and EgyptGeriatric health communicable diseases and Egypt
Geriatric health communicable diseases and Egypt
 
UTI-in-pregnancy in i pointofmidwifery.pdf
UTI-in-pregnancy in i pointofmidwifery.pdfUTI-in-pregnancy in i pointofmidwifery.pdf
UTI-in-pregnancy in i pointofmidwifery.pdf
 
Recent Advances in Endometriosis
Recent Advances in EndometriosisRecent Advances in Endometriosis
Recent Advances in Endometriosis
 
Recent Advances in Endometriosis
Recent Advances in EndometriosisRecent Advances in Endometriosis
Recent Advances in Endometriosis
 
Sexually transmitted diaseases
Sexually transmitted diaseasesSexually transmitted diaseases
Sexually transmitted diaseases
 
Infections of the urinary tract
Infections of the urinary tract Infections of the urinary tract
Infections of the urinary tract
 
1-macedaWhat other assessment data would be helpful for the nu.docx
1-macedaWhat other assessment data would be helpful for the nu.docx1-macedaWhat other assessment data would be helpful for the nu.docx
1-macedaWhat other assessment data would be helpful for the nu.docx
 
Assess the Prevalence of Self Reported Vaginal Discharge, Perceived Causes an...
Assess the Prevalence of Self Reported Vaginal Discharge, Perceived Causes an...Assess the Prevalence of Self Reported Vaginal Discharge, Perceived Causes an...
Assess the Prevalence of Self Reported Vaginal Discharge, Perceived Causes an...
 
Guideline itu en transplantado organo solido
Guideline itu en transplantado organo solidoGuideline itu en transplantado organo solido
Guideline itu en transplantado organo solido
 
Medicine (non resp) treatment guidelines Govt of India
Medicine (non resp) treatment guidelines Govt of India Medicine (non resp) treatment guidelines Govt of India
Medicine (non resp) treatment guidelines Govt of India
 
Gonorrhoea & Syphilis
Gonorrhoea & Syphilis Gonorrhoea & Syphilis
Gonorrhoea & Syphilis
 
Causes and Consequences of Back Pain
Causes and Consequences of Back PainCauses and Consequences of Back Pain
Causes and Consequences of Back Pain
 
STD's
STD'sSTD's
STD's
 
Acute pelvic inflammatory disease
Acute pelvic inflammatory diseaseAcute pelvic inflammatory disease
Acute pelvic inflammatory disease
 
Infections of the urinary tract final
Infections of the urinary tract finalInfections of the urinary tract final
Infections of the urinary tract final
 
Respond  on two different days who selected at least one different  .docx
Respond  on two different days who selected at least one different  .docxRespond  on two different days who selected at least one different  .docx
Respond  on two different days who selected at least one different  .docx
 
Comparative Study of Visual, Clinical and Microbiological Diagnosis of White ...
Comparative Study of Visual, Clinical and Microbiological Diagnosis of White ...Comparative Study of Visual, Clinical and Microbiological Diagnosis of White ...
Comparative Study of Visual, Clinical and Microbiological Diagnosis of White ...
 
FOURNIER’S GANGRENE: REVIEW OF 57 CASES IN TERTIARY INSTITUTION
FOURNIER’S GANGRENE: REVIEW OF 57 CASES IN TERTIARY INSTITUTIONFOURNIER’S GANGRENE: REVIEW OF 57 CASES IN TERTIARY INSTITUTION
FOURNIER’S GANGRENE: REVIEW OF 57 CASES IN TERTIARY INSTITUTION
 

Recently uploaded

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxAnaBeatriceAblay2
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 

Recently uploaded (20)

Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 

Syndromic approaches of sexually transmitted diseases

  • 1. 1
  • 2. COLLEGE OF MEDICINE AND HEALTH SCIENCE DEPARTMENT OF PUBLIC HEALTH (C1) SEMINAR TITLE:- SYNDROMIC APPROACHS TO STIs /STDs By: NUREDIN AMAN Moderator Dr. MAHDER K. 2
  • 3. OUTLINE  OVERVIEW OF MALE AND FEMALE GENITAL ANATOMY  DEFINE OF STDs  DEFINE EPIDEMOLOGY OF STDs  EXPLAIN SYNDROMIC APPROACH  ADVANTAGE AND DISADVANTAGE SYNDROMIC APPROACH  EXPLAIN MOST COMMON STI SYNDROME  REVIEW OF FLOW CHART  ETIOLOGY OF EACH SYNDROME  CLINICAL MANIFESTATION OF EACH SYNDROME  COMPLICATION OF ETIOLOGY  TREATMENT OF EACH SYNDROME 3
  • 4. Female reproductive  Vulva or Pudendum (external genitalia)  Labia majora  Labia minora  Vestibule of the vagina ( urogenital sinus) 4
  • 5. Conti……  Clitoris  Bulbs of the vestibule  Vagina  Uterus  Uterine tube /fallopian / oviducts  Ovaries (oocyte and hormones) 5
  • 8. 8
  • 9. Male reproductive organ  INCLUDE :  Supporting structures  Scrotum  Penis  Testes (gonads)  A system of ducts  Epididymis  Ductus (vas) deferens ( part of spermatic cord)  Ejaculatory ducts 9
  • 10. Conti…  Urethra ( part of excretory)  Accessory sex glands Seminal vesicles Prostate Bulbourethral glands (Cowper’s gland)_ 10
  • 13. Sexually transmitted disease  The term sexually transmitted diseases (STDs) is used to describe disorders spread by intimate contact.  Although this usually means sexual intercourse, it also includes close body contact, kissing, cunnilingus, anilingus, fellatio, mouth–breast contact, and anal intercourse.  Many STDs can also be transmitted to the fetus in utero by transplacental spread or passage through the birth canal and via lactation during the neonatal period. 13
  • 14. Sexually transmitted disease  A group of over 50 infectious diseases are included under STIs.  Although their etiologies involve a number of organisms, the infections present themselves commonly in the following syndromes (genital ulcer, urethral discharge, vaginal discharge, lower abdominal pain, scrotal swelling, inguinal bubo and neonatal conjunctivitis) 14
  • 15. Epidemiology of STIs  Even though there is little information on the incidence and prevalence of STIs in Ethiopia, the problem of STIs is generally believed to be similar to that of other developing countries.  According to 2011EDHS, 1%, of each Ethiopian women and men reported having had an STI in the past 12 months before the survey. Three percent of women and 2% of men reported having had an abnormal genital discharge.  Also 1% of each women and men reported having had a genital sore or ulcer in the 12 months preceding the survey. These numbers may be underestimated because respondents could be embarrassed or ashamed to admit having STIs. 15 15
  • 16. Conti..  The single point adult HIV prevalence estimate for the year 2014 is 1.14%. Taking syphilis and HIV as proxy indicators, the STI prevalence is in a declining trend.  In the STI surveillance study which was conducted from January - June 2013 in 8 health facilities located in Amhara, Oromia and Addis Ababa by EHNRI in collaboration with CDC-E, a total of 636 STI cases were reported from eight sentinel surveillance sites and the commonest syndrome was vaginal discharge (50%), followed by urethral discharge (31%), genital ulcerative disease (9%), lower abdominal pain (7.3%) and two syndrome were present in few patients (3%). 16
  • 17. Conti..  About 16% of the STI patients were co-infected with HIV (8.1% male and 21%female) and HIV prevalence is higher on STI patients with lower abdominal pain (41%) and genital ulcer (24.5%). Young people, in the age group 20-34 yrs, were the highly affected ones (68.2%), with a larger proportion being females (61%) 17
  • 18. Conti…  Sexually transmitted infections remain a public health problem of major importance in both developed and developing countries, but are specially so in developing countries where access to diagnostic and treatment facilities is inadequate, very limited or non existent at all. In many developing countries throughout the world STIs rank among the top ten conditions for which adults seek health care. These diseases are important for three reasons, because of their magnitude, their potential for causing serious complications and their linkage with HIV/AIDS. 18
  • 19. Conti..  According to a WHO report, in 1995 an estimated 340 million new cases of the five most common curable STIs occurred  globally in both men and women of 15 - 49 age range. On average an estimated 930,000 people are infected every day with curable STI globally. 19
  • 20. 20
  • 21. 21
  • 22. Syndromic approach  Syndromic approach is called “Comprehensive approach” because in addition to the provision of treatment it includes: education of the patient, condom supply, counseling, partner notification and management and HIV testing and counseling  Treatment for each syndrome is directed against the main organisms within that geographical setting responsible for the syndrome.  The syndromic approach has been shown to be highly effective for the management of majority of the STI. Prompt and efficient case detection and treatment, results in immediate health benefits for individual patients. 22
  • 23. 23
  • 24. The commonly encountered STI syndromes are:  Urethral discharge in men  Genital ulcer  Vaginal discharge  Lower abdominal pain in women  Inguinal bubo  Scrotal swelling  Neonatal conjunctivitis. 24
  • 25. 25
  • 26.  Introduction to Flow Charts  For each syndrome a clinical algorithm is developed to be followed in managing STI patients.  A flow chart (also known as an algorithm) is a decision and action tree. It is like a map that guides the health worker to go through a series of decisions and actions. Each decision or action is enclosed in a box, with one or two routes leading out to another box, containing another decision or action. 26
  • 27. Conti..  Benefits of using flow-charts  They can be used at any time in all types of health facilities.  They suggest clear decisions  Each flow-chart is made up of a series of three steps.  These are:  The clinical problem: is what the patient complains of, i.e. the patient’s presenting symptoms  The decision that needs to be taken: this is the box, which requires further information, which the health care provider finds out by taking a history or examining the patient.  The action that needs to be carried out: Each of the exit paths leads to an action or do box. This is the box that instructs the service provider on what action to take. 27
  • 28. 28
  • 29. URETHRAL DISCHARGE SYNDROME  Urethral discharge is the presence of abnormal secretions from the distal part of the urethra and it is the characteristic manifestation of urethritis.  Urethritis is usually due to sexually transmitted infections although urinary tract infections may produce similar symptoms.  Urethral discharge is one of the commonest sexually transmitted infections among men in our country. Usually urethral discharge is accompanied by burning sensations (dysuria) during micturition. 29
  • 30. CONTI…  Person with urethral discharge can also have  increased frequency  urgency of urination  itching sensation of urethra  The amount and nature of the discharge vary according to the causative agents and other factors like prior treatments with antibiotics. 30
  • 31. Conti…  The appearance of the discharge can be  purulent or mucoid  clear, white, or yellowish-green  Sometimes it can be associated with scrotal swelling and pain which tends to be unilateral. 31
  • 32.  The causative agents of urethral discharge syndrome are many; but the two most common causative agents of the syndrome are  Neisseria gonorrhea  Chlamydia trachomatis ( 81% and 36.8% respectively according the 2014 EPHI gonococcal antimicrobial sensitivity validation study ) .  Some of the other causative micro-organisms are mycoplasma genitalium,Trichomonas vaginalis, and Ureaplasma urealyticum.  Most of the time urethral discharge is due to mixed infection of Neisseria gonorrhea and Chlamydia trachomatis ETIOLOGY OF URETHRAL DISCHARGE SYNDROME 32
  • 33.  The urethritis caused by N. gonorrhea has usually an acute onset with profuse and purulent discharge and  The one caused by C. trachomatis has sub-acute onset with scant mucopurulent discharge.  The other common signs and symptoms are burning sensation during micturition, urgency and frequency of urination with itching sensation of the urethra.  The signs and symptoms of complications of the syndrome are testicular pain and swelling, polyarthralgia, tenosynovitis, arthritis, skin lesions and constitutional symptoms CLINICAL MANIFESTATIONS OF URETHRAL DISCHARGE SYNDROME 33
  • 34. 34
  • 35. COMPLICATIONS OF URETHRAL DISCHARGE SYNDROME  :   Acute complications • Disseminated gonococci syndrome • Perihepatitis • Acute epididymo-orchitis  Chronic complications  • Urethral stricture  • Infertility  • Reiter’s syndrome(urethritis , conjunctivitis $ cervicitis) 35
  • 36. 36
  • 37. TREATMENT  Ceftriaxone 250mg IM stat/Spectinomycin 2 gm IM stat Plus  Azithromycin 1gm po stat/Doxycycline 100 mg po bid for 7 days/Tetracycline 500 mg po qid for 7 days/Erythromycin 500 mg po qid for 7 days in cases of contraindications for Tetracycline (children and pregnancy)  Note: The preferred regimen is Ceftriaxone 250mg IM stat plus Azithromycin 1gm po stat 37
  • 38.  Metronidazole 2 gm po. stat/Tinidazole 1gm po once for 3 days (Avoid Alcohol!)  • Azithromycin 1 g orally in a single dose (only if not used during the initial episode to address doxycycline resistant M.genitalium) TREATMENT OF PERSISTENT/RECURRENT URETHRITIS SYNDROME 38
  • 39. GENITAL ULCER SYNDROME  Genital ulcer is an open sore or a break in the continuity of the skin or mucous membrane of the genitalia as a result of sexually acquired infections.  Commonly genital ulcer is caused by bacteria and viruses.  Genital ulcer facilitates transmission of HIV more than other sexually transmitted infections because it disrupts continuity of skins and mucous membranes significantly 39
  • 40. 40
  • 41. ETIOLOGY OF GENITAL ULCER SYNDROME  There are different kinds of bacteria and viruses which cause genital ulcer.  Some of the common etiologies of genital ulcer syndrome are:  Herpes simplex virus (HSV-1 and HSV-2)  Treponema pallidum  Haemophilius ducreyia  Chlamydia trachomatis 41
  • 42. CLINICAL MANIFESTATION Genital ulcer is caused by different causative agents and due to this fact genital ulcer has different kinds of clinical manifestations. Common clinical manifestations of genital ulcer are: • Constitutional symptoms such as fever, headache, malaise and muscular pain • Recurrent painful vesicles and irritations • Shallow and non-indurated tender ulcers 42
  • 43. Conti... • Common sites in male are  glance penis , prepuce and penile shaft • Common sites in women are  vulva $ perineum,  vagina and cervix and can cause occasionally severe vulvo- vaginitis and necrotizing cervicitis • Painless indurated ulcer(Chancre) • Regional lymph adenopathy 43
  • 44. COMPLICATIONS OF GENITAL ULCER SYNDROME • Locally destructive granulomatous lesions occur (Gummas) on the skin, liver, bones, or other organs • Tabes dorsalis and dementia, often with paranoid features • Latent meningovascular parenchymatous • Optic atrophy • General paresis • Aortic aneurysm and aortic valve insufficiency 44
  • 45. 45
  • 46. TREATMENT OF GENITAL ULCER SYNDROME  1. Treatment for Non- Vesicular Genital Ulcer: Benzathine penicillin 2.4 million units IM stat /Doxycycline(in penicillin allergy) 100mg bid for 14 days plus  Ciprofloxacin 500mg bid orally for 3 days /Erythromycin 500mg tab qid for 7 days plus Acyclovir 400mg tid orally for 10 days (or 200mg five times per day of 10 day)  2. Treatment for Vesicular, multiple or recurrent genital ulcer Acyclovir 200 mg five times per day for 10 days Or Acyclovir 400 mg tid for 7 day  3. Treatment for recurrent infection: Acyclovir 400 mg tid for 7days 46
  • 47. VAGINAL DISCHARGE SYNDROME  Physiologically women have vaginal discharge which is white mucoid, odor less and nonirritant, thin or thick based on menstrual cycle. There is individual variation in the amount of normal vaginal discharges.  Abnormal vaginal discharge which is STI related is abnormal in color, odor and amount.  In another word abnormal vaginal discharge is there when a women notices a change in color, odor and amount accompanied by pruritus. 47
  • 48. 48
  • 49. ETIOLOGY OF VAGINAL DISCHARGE SYNDROME  The most common causes of vaginal discharge syndrome are  Bacterial vaginosis (Gardnerella vaginalis) is the leading cause of vaginal discharge in Ethiopia followed by  candidiasis,  trichomoniasis,  gonococcal and  chlamydia cervicitis in that order. 49
  • 50. CLINICAL MANIFESTATIONS The classical manifestation of vaginal discharge is discharge from the vagina. The discharge can be • Thin, homogenous whitish discharge with fishy odor • Thick, profuse, malodorous, yellow-green, frothy itchy • Purulent exudate from the cervical Os • White , thick and curd like discharge coating the walls of the vagina 50
  • 51. Conti…  The other manifestations are:  vulvo-vaginal pruritus  , irritation of vulva,  dyspareunia, dysuria, and frequency of urination. Physical examination may reveal dry congestion of the vulva with discharge. There can be signs of cervicitis during speculum examination which are redness and contact bleeding from the cervix, spotting and endo cervical discharge. 51
  • 52. Conti...  The following are the common risk factors for development of vaginal discharge syndrome secondary to cervicitis:  Multiple sexual partners in the last 3 month  New sexual partner in the last 3 month  Ever traded sex  Age below 25 years  The presences of one or more risk factor suggest cervicitis. 52
  • 53. COMPLICATIONS  Untreated vaginal discharge can cause reproductive, sexual and other health complications. Some of the complications are: • Pelvic Inflammatory Disease (PID) • Adhesions and intestinal obstruction • Ectopic pregnancy • Premature Rupture of Membrane (PROM) in case of pregnant wom • Pre-term labor in case of pregnant women • Low birth weight • Infertility 53
  • 54. 54
  • 55. TREATMENT OF VAGINAL DISCHARGE SYNDROME  Risk Assessment Positive  Ceftriaxone 250mg IM stat/Spectinomycin 2 gm IM stat Plus Azithromycin 1gm po stat/Doxycycline 100 mg po bid Plus Metronidazole 500 mg bid for 7 days If discharge is white or curd-like add Clotrimazole vaginal pessary 200 mg at bed time for 3 days or 7 days 55
  • 56. Conti…  Risk Assessment Negative  Metronidazole 500 mg bid for 7 days If discharge is white or curd-like add  Clotrimazole vaginal pessary 200 mg at bed time for 3 days 56
  • 57. 5. LOWER ABDOMINAL PAIN/PELVIC INFLAMMATORY DISEASE (PID)  Pelvic inflammatory disease (PID) refers to a clinical syndrome resulting from ascending infection from the cervix and/or vagina.  PID comprises a spectrum of inflammatory disorders of the upper female genital tract, including any combination of endometritis, salpingitis, tubo-ovarian abscess and pelvic peritonitis.  The inflammation may also spread to the liver, spleen or appendix.  The vast majority of PID with or without pelvic abscess improves with antibiotics alone and the fever usually subsides in less than 72 hours. However, failure to improve within 72 hours after antibiotic treatment indicates failure of medical treatment and the patient should be referred for surgical evaluation and treatment. 57
  • 58. ETIOLOGY PID is frequently poly-microbial. The commonest pathogens associated with PID, which are transmitted sexually, are C. trachomatis and N. gonorrhoea. Other causes which may or may not be transmitted sexually include: • Mycoplasma genitalium • Bacteroides species • E. coli • H. influenza • Streptococcus 58
  • 59. Clinical manifestation  The commonest manifestations of pelvic inflammatory diseases include • Lower abdominal pain • Abnormal vaginal discharge • Inter-menstrual or post coital bleeding • Dysuria • Backache • Fever, nausea and vomiti 59
  • 60. COMPLICATIONS OF LOWER ABDOMINAL PAIN SYNDROME If patients with LAP syndrome are not treated appropriately and adequately the following life threatening complications may occur. • Peritonitis and intra-abdominal abscess • Adhesions and intestinal obstruction • Ectopic pregnancy • Infertility • Chronic pelvic pain • Recurrent PID 60
  • 61. 61
  • 62. TREATMENT OF LOWER ABDOMINAL PAIN SYNDROME The treatment regimen should cover all possible causative agents. The recommended treatment regimen for lower abdominal pain syndrome is: For outpatient  Ceftriaxone 250 mg IM stat /Spectinomycin 2gm i.m stat Plus Azithromycin 1gm po stat/Doxycycline 100 mg po b.i.d for 14 days Plus Metronidazole 500 mg po b.i.d for 14 day 62
  • 63. Conti….  INDICATION FOR INPATIENT TREATMENT  Hospitalization of patients with acute PID should be seriously considered when:  The diagnosis is uncertain  • Surgical emergencies such as appendicitis and ectopic pregnancy cannot be exclude  • Pelvic abscess is suspected  • Severe illness precludes management on an outpatient basis  • The patient is pregnant  • Patient has failed to respond to outpatient therapy.  • PID in HIV patients 63
  • 64. SCROTAL SWELLING SYNDROME  Scrotal swelling can be caused by trauma, tumor, and torsion of the testis or inflammation of the epididymis. Mostly the inflammation of the epididymis is caused by sexually transmitted diseases. The cause of scrotal swelling can vary depending on the age of the patient. Among patients who are younger than 35 years, the swelling is likely to be caused by sexually transmitted infections. 64
  • 65. 65
  • 66. ETIOLOGY SCROTAL SWELLING SYNDROME The cause of scrotal swelling syndrome can be infectious or non- infectious. Infectious scrotal swelling caused by: • N. gonorrhea • C. trachomatis • T. pallidum • M. tuberculosis • Mumps virus 66
  • 67. CLINICAL MANIFESTATIONS OF SCROTAL SWELLING Scrotal swelling can manifest itself with different signs and symptoms. Some of the signs and symptoms of scrotal swelling are: • Pain and swelling of the scrotum • Tender and hot scrotum on palpation • Edema and erythema of the scrotum • Dysuria • Sometimes frequency and urethral discharge can be thereIt is important to exclude other causes of scrotal swelling like testicular torsion, trauma, and incarcerated inguinal hernia as they may require urgent referral for proper surgical evaluation and management 67
  • 68. COMPLICATIONS OF SCROTAL SWELLING SYNDROME The common complications of scrotal swelling syndrome are: • Destruction and scarring of testicular tissues • Infertility • Impotence • Prostatitis 68
  • 69. 69
  • 70. TREATMENT OF SCROTAL SWELLING SYNDROME Ceftriaxone 250mg i.m stat/ Spectinomycin 2gms i.m stat. Plus Azithromycin 1gm po stat/ Doxycycline 100mg po bid for 7 days/ Tetracycline 500mg qid for 7 days 70
  • 71. INGUINAL BUBO SYNDROME (SWOLLEN GLANDS  INGUINAL BUBO SYNDROME (SWOLLEN GLANDS) Inguinal bubo is defined as swelling of inguinal lymph nodes as a result of STIs. It should be remembered that infections on the lower extremities or in the perineum could produce swelling of the inguinal lymph nodes but strictly speaking this regional enlargement of lymph nodes should not be regarded as inguinal bubo. 71
  • 72. 72
  • 73. ETIOLOGY The common causes of inguinal and femoral bubo are: • Chlamydia trachomatis (L1, L2 and L3) • Klebsiella granulomatis (donovanosis) • Treponema pallidum • Haemophilius ducreyia CLINICAL MANIFESTATIONS • Constitutional symptoms of fever, headache and pain • Tender unilateral or bilateral lymphadenopathy forms a classical “groove sign” in the inguinal area • Fluctuant abscess formation which forma coalesce mass (bubo) • Some time concomitantly occur with genital ulcer 73
  • 74. COMPLICATIONS  Fistula or sinus formation  Multiple draining sinus  Extensive ulceration of genitalia  Extensive scarring  Proctocolitis with tenesmus and bloody purulent discharge.  Retroperitoneal lymphadenopathy  Chronic untreated LGV may result in lymphatic obstruction, elephantiasis of the genitalia  Rarely hematogenous dissemination to lung, liver, spleen and bone 74
  • 75. 75
  • 76.  TREATMENT OF INGUINAL BUBO  The treatment regimen for inguinal bubo syndrome in Ethiopia is:  Ciprofloxacin 500mg bid orally for 3 days  Plus  Doxycycline 100 mg bid orally for 14 days /Erythromycin 500mg po qid for 14 days.  If patient have genital ulcer , add Acyclovir 400mg tid orally for 10 days( or 200mg five times per day for 10 days)  Note: surgical incisions are contraindicated; aspirate pus with hypodermic needle through the health skin 76
  • 77. NEONATAL CONJUNCTIVITIS  Neonatal conjunctivitis (ophthalmia neonatorum) is an ocular redness, swelling and drainage which can be sometimes purulent due to pathogenic agents or irritant chemicals occurring in infants less than 4 weeks of age.  In cases of neonatal conjunctivitis due to pathogenic agents, the neonates get the infections from their  infected mothers. Neonatal conjunctivitis can cause loss of sight if it is not managed properly and promptly.  Neonatal conjunctivitis due to sterile chemical irritants can be resolved by itself within 48 hours without any intervention. 77
  • 78. 78
  • 79. ETIOLOGY OF NEONATALCONJUNCTIVITIS can be disease causing micro-organisms or sterile chemicals which are irritant and applied for preventive purposes. Some of the common etiologic causes of neonatal conjunctivitis are:  N. gonorrhea  S. pneumoniae  H. influenzae  S. aureus  The commonest irritant chemical that causes neonatal conjunctivitis is silver nitrate solution, which is applied to the eye of the neonate for prophylactic purposes 79
  • 80. Conti… COMMON RISK FACTORS OF NEONATAL CONJUNCTIVITIS • Maternal infection with STI • Exposure of the infant to infectious organisms • Inadequacy of ocular prophylaxis immediately after birth • Premature rupture of membrane • Ocular trauma during delivery 80
  • 81. CLINICAL MANIFESTATIONS OF NEONATAL CONJUNCTIVITIS The common clinical presentations of neonatal conjunctivitis (ophthalmia neonatorum) are: • Red and edematous conjunctiva • Edematous eye lead • Discharge which may be purulent • Orbital cellulitis in more serious cases 81
  • 82. COMPLICATIONS OF NEONATAL CONJUNCTIVITIS Neonatal conjunctivitis can lead to some serious ophthalmic complications if it is not managed promptly. Some of the complications of neonatal conjunctivitis (ophthalmia neonatorum) are: • Pseudo membrane formation • Corneal edema • Thickened palpebral conjunctiva • Corneal opacification • Corneal perforation • Endophthalmitis • Blindness 82
  • 83. 83
  • 84. TREATMENT OF NEONATAL CONJUNCTIVITIS (OPHTHALMIA NEONATORUM  Ceftriaxone 50mg/kg IM stat maximum dose 125/ Spectinomycin 25 mg/kg IM stat maximum dose 75mg plus  Erythromycin 50mg/kg orally in four divided doses for 14 days Note: TTC is used as prophylaxis for neonatal conjunctivitis but note for treatment 84
  • 85.  REFERENCE  NATIONAL GUIDELINES FOR THE MANAGEMENT OF STDs/STIs USING SYNDROMIC APPROACH ( FMOH) JULY 2015  EPHTI  WHO GUIDELINES FOR THE MANAGEMENT OF STDs/STIs USING SYNDROMIC APPROACH JULY 2021 85